A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension
| Autor: | Gradman, Alan H., Brady, William E., Gazdick, Lisa P., Lyle, Paulette, Zeldin, Robert K. |
|---|---|
| Zdroj: | In Clinical Therapeutics July 2002 24(7):1049-1061 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect